A nurse is reviewing the laboratory results of an adolescent who has anorexia nervosa. Which of the following findings should the nurse expect?

A. Summarize the objectives the client achieved during the relationship:
This intervention is more appropriate for the termination phase of the nurse-client relationship. During termination, the nurse summarizes the progress made, goals achieved, and skills learned during the therapeutic relationship. This helps both the nurse and the client reflect on the journey and celebrate accomplishments.

B. Present issues regarding confidentiality:
Discussing confidentiality is crucial and typically occurs in the orientation phase of the nurse-client relationship. Establishing trust and clarifying the boundaries of confidentiality early in the relationship helps the client feel secure and promotes open communication. This choice is relevant during the initial stages of the therapeutic relationship.

C. Promote the client's problem-solving skills:
This is the correct choice for the working phase of the nurse-client relationship. In this phase, the focus is on active problem-solving, exploring feelings and thoughts, and encouraging the client to develop coping strategies. The nurse supports the client in identifying problems, generating solutions, and implementing effective strategies. Promoting the client's problem-solving skills is a central aspect of therapeutic work during this phase.

D. Identify the responsibilities of the client and nurse:
Clarifying the responsibilities of both the client and nurse is essential to establish clear roles and expectations. This usually occurs in the orientation phase. During this phase, the nurse explains the purpose of the therapeutic relationship, the roles of both parties and the boundaries of the nurse-client interaction. Establishing clear responsibilities helps create a foundation for a respectful and effective therapeutic alliance.

A. Magnesium hydroxide:
Magnesium hydroxide is an antacid commonly used to relieve indigestion and heartburn. It does not have any known significant interactions with tranylcypromine. MAOIs typically do not interfere with antacids.

B. Ibuprofen:
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to reduce pain and inflammation. It does not have specific interactions with tranylcypromine. However, individuals taking MAOIs should be cautious about using NSAIDs due to the potential risk of bleeding, especially gastrointestinal bleeding. While it's not a direct interaction, it's generally advisable for individuals taking MAOIs to consult their healthcare provider before using NSAIDs.

C. Ranitidine:
Ranitidine is an H2 blocker used to reduce stomach acid production. It does not have any known significant interactions with tranylcypromine. H2 blockers like ranitidine are often used to manage gastrointestinal issues and are generally considered safe when taken with MAOIs.

D. Pseudoephedrine:
Pseudoephedrine is a decongestant commonly found in cold and allergy medications. It can cause a dangerous increase in blood pressure when combined with MAOIs, potentially leading to a hypertensive crisis. Due to this serious interaction, individuals taking MAOIs are strongly advised to avoid medications containing pseudoephedrine.